Furthermore, most of primary PCas with high levels of TOP2A or KDM1A belonged to the PCa subtype characterized by copy number alterations of the tumor suppressor gene PTEN and containing ERG fusion, which is the subtype characterizing PCa with high BAZ2A expression (Pietrzak et al, 2020) (Fig 5G). The gene discussed is BAZ2A; the disease is posterior cortical atrophy.